» Articles » PMID: 35279162

Impact of Prior Underinsurance on Cervical Cancer Screening Among Davidson County, Tennessee, Women Diagnosed with Invasive Cervical Cancer, 2008-2018

Overview
Publisher Biomed Central
Date 2022 Mar 13
PMID 35279162
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: We sought to investigate the association between insurance coverage history and cervical cancer screening among Davidson County, Tennessee, women diagnosed with incident cervical cancer.

Methods: We reviewed medical records of women diagnosed with invasive cervical cancer from 2008 through 2018 identified via the state's cancer registry and by active surveillance of diagnostic pathology reports for the HPV-IMPACT project. Per 2012 United States Preventive Services Task Force recommended cervical cancer screening guidelines, women were characterized into three screening history categories: "no screening", "no follow-up" and "test/screening failure". Multivariable logistic regression measured the association of prior inadequate insurance (underinsurance) and screening history ("no screening/no follow-up" compared to "test/screening failure").

Results: Of 212 women, most (77%) had not undergone recommended cervical cancer screening or follow-up prior to cancer diagnosis. Overall, 28% of women had history of underinsurance in 5 years prior to diagnosis. In adjusted analyses, underinsured women were more likely to have a "no screening/no follow-up" prior to cancer diagnosis (aOR 4.26; 95% CI 1.15-15.80) compared to "test/screening failure" history. Non-white race (aOR 2.73; 95% CI 0.98-7.61), older age (aOR 1.03 per year; 95% CI 1.00-1.07), and history of smoking (aOR 4.07; 95% CI 1.54-10.74) were also associated with increased likelihood of "no screening/no follow-up".

Conclusions: Previous underinsurance was independently associated with non-adherence to cervical cancer screening and follow-up guidelines among women with incident cervical cancer. Further study of factors contributing to inadequate cervical cancer screening and interventions to increase cervical cancer screening in high-risk populations is needed.

Citing Articles

Racial/Ethnic Disparities in Cervical Cancer Stage at Diagnosis: Mediating Effects of Neighborhood-level Socioeconomic Deprivation.

Sokale I, Oluyomi A, Montealegre J, Thrift A Cancer Epidemiol Biomarkers Prev. 2023; 32(6):818-824.

PMID: 37067295 PMC: 10233349. DOI: 10.1158/1055-9965.EPI-23-0038.

References
1.
Cowburn S, Carlson M, Lapidus J, DeVoe J . The association between insurance status and cervical cancer screening in community health centers: exploring the potential of electronic health records for population-level surveillance, 2008-2010. Prev Chronic Dis. 2013; 10:E173. PMC: 3809921. DOI: 10.5888/pcd10.130034. View

2.
Spayne J, Ackerman I, Milosevic M, Seidenfeld A, Covens A, Paszat L . Invasive cervical cancer: a failure of screening. Eur J Public Health. 2007; 18(2):162-5. DOI: 10.1093/eurpub/ckm043. View

3.
Stumbar S, Stevens M, Feld Z . Cervical Cancer and Its Precursors: A Preventative Approach to Screening, Diagnosis, and Management. Prim Care. 2019; 46(1):117-134. DOI: 10.1016/j.pop.2018.10.011. View

4.
Watson M, Benard V, King J, Crawford A, Saraiya M . National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey. Prev Med. 2017; 100:243-247. PMC: 5573169. DOI: 10.1016/j.ypmed.2017.05.004. View

5.
Hariri S, Unger E, Powell S, Bauer H, Bennett N, Bloch K . The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions. Cancer Causes Control. 2011; 23(2):281-8. DOI: 10.1007/s10552-011-9877-6. View